IE
IE · IE · IE-PA-EU/1/05/324/001
Naglazyme 1 mg/ml concentrate for solution for infusion
ATC A16AB08
Last synced from HPRA (Ireland) on
Identification
ManufacturerBioMarin International Limited
CountryIE (IE)
ATC codeA16AB08
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/05/324/001
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"A16AB08"
],
"strength": null,
"pa_number": "EU/1/05/324/001",
"substances": [
"Galsulfase"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "24/01/2006",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code A16AB08.
- FINaglazymeBiomarin International Limited
- PLNaglazymeBioMarin International Ltd.
- 🇨🇭NaglazymeDRAC AG
- DKNaglazymeBioMarin International Limited
- NONaglazymeBioMarin International Limited
- ISNaglazymeBioMarin International Limited
- CZNAGLAZYMEBioMarin International Limited, Dublin
- 🇺🇸NAGLAZYMEBioMarin Pharmaceutical Inc.
Access this data programmatically
Query Naglazyme 1 mg/ml concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.